-
Published on Oct 18, 2016
Pharmaceuticals
and services group Clinigen Group PLC (LON:CLIN) has opened an office
in Tokyo from which it will run its newly-launched Japanese business.
The establishment of Clinigen KK further expands the group's presence in
Asia, following Clinigen's acquisition of Link Healthcare in 2015.
Chief executive Shaun Chilton tells Proactive: ''The obvious point about Japan is that it's the second biggest pharmaceuticals market in the world so it's difficult to ignore.''
''It's another important step in building our global footprint'', Chilton added.
The move will enable Clinigen to be more hands-on in the marketing of its lead speciality pharmaceutical product Foscavir, which is used to treat cytomegalovirus retinitis – inflammation of the retina - in patients with AIDS and herpes infections.
http://www.4-traders.com/CLINIGEN-GROUP-PLC-11560493/
http://www.clinigengroup.com/overview
Chief executive Shaun Chilton tells Proactive: ''The obvious point about Japan is that it's the second biggest pharmaceuticals market in the world so it's difficult to ignore.''
''It's another important step in building our global footprint'', Chilton added.
The move will enable Clinigen to be more hands-on in the marketing of its lead speciality pharmaceutical product Foscavir, which is used to treat cytomegalovirus retinitis – inflammation of the retina - in patients with AIDS and herpes infections.
http://www.4-traders.com/CLINIGEN-GROUP-PLC-11560493/
http://www.clinigengroup.com/overview
Hello from #EONS10! If you’re in Dublin today come and meet the #ClinigenSP team at booth 20 to talk about #Savene for #extravasation pic.twitter.com/vthP664qBl— Clinigen Group (@Clinigen) October 18, 2016
No comments:
Post a Comment